209 related articles for article (PubMed ID: 10894286)
1. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
[TBL] [Abstract][Full Text] [Related]
2. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
[TBL] [Abstract][Full Text] [Related]
3. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
[TBL] [Abstract][Full Text] [Related]
4. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
[TBL] [Abstract][Full Text] [Related]
5. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
[TBL] [Abstract][Full Text] [Related]
6. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
[TBL] [Abstract][Full Text] [Related]
7. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
Tyring S; Belanger R; Bezwoda W; Ljungman P; Boon R; Saltzman RL;
Cancer Invest; 2001; 19(1):13-22. PubMed ID: 11291551
[TBL] [Abstract][Full Text] [Related]
9. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
[TBL] [Abstract][Full Text] [Related]
10. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC
J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of famciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
Ashton RJ; Abbott KH; Smith GM; Sutton D
J Antimicrob Chemother; 1994 Aug; 34(2):287-90. PubMed ID: 7814291
[No Abstract] [Full Text] [Related]
14. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults.
Pott Junior H; de Oliveira MFB; Gambero S; Amazonas RB
Int J Infect Dis; 2018 Jul; 72():11-15. PubMed ID: 29746903
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus infection.
Whitley RJ
Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
[TBL] [Abstract][Full Text] [Related]
17. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
[TBL] [Abstract][Full Text] [Related]
18. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.
Tyring SK; Diaz-Mitoma F; Shafran SD; Locke LA; Sacks SL; Young CL
J Cutan Med Surg; 2003; 7(6):449-54. PubMed ID: 15931690
[TBL] [Abstract][Full Text] [Related]
19. One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patients.
Leone P; Abudalu M; Mitha E; Gani M; Zhou W; Hamed K
Curr Med Res Opin; 2010 Mar; 26(3):653-61. PubMed ID: 20070143
[TBL] [Abstract][Full Text] [Related]
20. Famciclovir/penciclovir.
Sacks SL; Wilson B
Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
